Financhill
Back

Krystal Biotech, Inc. 10K Form

Buy
77

KRYS
Krystal Biotech, Inc.

Last Price:
$253.54
Seasonality Move:
5.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KRYS News And Ratings

See the #1 stock for the next 7 days that we like better than KRYS

KRYS Financial Statistics

Sales & Book Value

Annual Sales: $290.5M
Cash Flow: $38M
Price / Cash Flow: 44.97
Annual Sales: $39.26
Price / Book: 6.36

Profitability

EPS (TTM): 6.66700
Net Income (TTM): $198.9M
Gross Margin: $263.7M
Return on Equity: 19.91%
Return on Assets: 18.11%

Krystal Biotech, Inc. Earnings Forecast

Key Krystal Biotech, Inc. Financial Ratios

  • The Gross Profit Margin over the past 9 years for KRYS is 90.77%.
  • The Selling, General & Administrative Expenses for KRYS have been equal to 39.13% of Gross Profit Margin.
  • The Research & Development expenses have been 18.44% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of KRYS is 30.69% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Krystal Biotech, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KRYS
CUSIP: 501147
Website: krystalbio.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 10.14
Quick Ratio: 9.43

Price-to-Earnings

Trailing P/E Ratio: 83.26
Forward P/E Ratio: 30.07

KRYS Technical Analysis vs Fundamental Analysis

Buy
77
Krystal Biotech, Inc. (KRYS) is a Buy

Is Krystal Biotech, Inc. a Buy or a Sell?